Role of intramuscular enzymatic changes in the development of muscular weakness in rats with experimental allergic neuritis
- 1 May 1984
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 84 (2) , 326-337
- https://doi.org/10.1016/0014-4886(84)90229-2
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Two different modes of enzymatic changes in serum with progression of Duchenne muscular dystrophyClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Various enzyme activities in muscle and other organs of dystrophic mice.Journal of Clinical Investigation, 1981
- Forphenicine, an inhibitor of alkaline phosphatase produced by actinomycetes.The Journal of Antibiotics, 1978
- Amastatin, an inhibitor of aminopeptidase A, produced by Actinomycetes.The Journal of Antibiotics, 1978
- Release of a plasma membrane-bound triaminopeptidase activity from mammalian cells by thermolysinBiochemical and Biophysical Research Communications, 1978
- Induction of experimental allergic neuritis with a peptide from myelin P2 basic proteinNature, 1977
- The inhibition by pepstatin of cathepsin D and autolysis of dystrophic muscleLife Sciences, 1976
- Aminopeptidase activities on the surface of mammalian cellsBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- EFFECT OF PEPSTATIN ON ACID PROTEASESThe Journal of Antibiotics, 1971
- BIOLOGICAL ACTIVITIES OF LEUPEPTINSThe Journal of Antibiotics, 1969